These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2962478)

  • 1. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome.
    Grines CL; Topol EJ; Bates ER; Juni JE; Walton JA; O'Neill WW
    Am Heart J; 1988 Jan; 115(1 Pt 1):1-7. PubMed ID: 2962478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.
    Califf RM; Topol EJ; George BS; Boswick JM; Lee KL; Stump D; Dillon J; Abbottsmith C; Candela RJ; Kereiakes DJ
    Circulation; 1988 May; 77(5):1090-9. PubMed ID: 2966016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
    J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial.
    Williams DO; Ruocco NA; Forman S
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):45B-50B. PubMed ID: 2959715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty.
    Abbottsmith CW; Topol EJ; George BS; Stack RS; Kereiakes DJ; Candela RJ; Anderson LC; Harrelson-Woodlief SL; Califf RM
    J Am Coll Cardiol; 1990 Oct; 16(4):770-8. PubMed ID: 1698843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European Cooperative Study Group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty.
    de Bono DP
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):20A-23A. PubMed ID: 2973485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.
    Juliard JM; Himbert D; Cristofini P; Desportes JC; Magne M; Golmard JL; Aubry P; Benamer H; Boccara A; Karrillon GJ; Steg PG
    Am J Cardiol; 1999 Feb; 83(3):305-10. PubMed ID: 10072213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.
    Ellis SG; Topol EJ; George BS; Kereiakes DJ; Debowey D; Sigmon KN; Pickel A; Lee KL; Califf RM
    Circulation; 1989 Nov; 80(5):1159-65. PubMed ID: 2509102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
    Ohman EM; Califf RM; Topol EJ; Candela R; Abbottsmith C; Ellis S; Sigmon KN; Kereiakes D; George B; Stack R
    Circulation; 1990 Sep; 82(3):781-91. PubMed ID: 2394002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
    White HD; French JK; Hamer AW; Brown MA; Williams BF; Ormiston JA; Cross DB
    J Am Coll Cardiol; 1995 Jan; 25(1):218-23. PubMed ID: 7798505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myocardial infarction associated with single vessel coronary artery disease: an analysis of clinical outcome and the prognostic importance of vessel patency and residual ischemic myocardium.
    Wilson WW; Gibson RS; Nygaard TW; Craddock GB; Watson DD; Crampton RS; Beller GA
    J Am Coll Cardiol; 1988 Feb; 11(2):223-34. PubMed ID: 3339161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
    Morris JA; Muller DW; Topol EJ
    Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study.
    Wall TC; Mark DB; Califf RM; Collins G; Burgess R; Skelton TN; Hinohara T; Kong DF; Mantell S; Aronson L
    Am J Cardiol; 1989 Feb; 63(7):423-8. PubMed ID: 2492742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.
    Topol EJ; Califf RM; George BS; Kereiakes DJ; Abbottsmith CW; Candela RJ; Lee KL; Pitt B; Stack RS; O'Neill WW
    N Engl J Med; 1987 Sep; 317(10):581-8. PubMed ID: 2956516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial.
    Topol EJ; Califf RM; Kereiakes DJ; George BS
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):65B-74B. PubMed ID: 2959716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Gibson CM; Cannon CP; Piana RN; Breall JA; Sharaf B; Flatley M; Alexander B; Diver DJ; McCabe CH; Flaker GC
    J Am Coll Cardiol; 1995 Mar; 25(3):582-9. PubMed ID: 7860900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
    Topol EJ; Califf RM; Vandormael M; Grines CL; George BS; Sanz ML; Wall T; O'Brien M; Schwaiger M; Aguirre FV
    Circulation; 1992 Jun; 85(6):2090-9. PubMed ID: 1591828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.
    Giannitsis E; Potratz J; Wiegand U; Stierle U; Djonlagic H; Sheikhzadeh A
    Heart; 1997 Jun; 77(6):512-6. PubMed ID: 9227293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group.
    Arnold AE; Simoons ML; Van de Werf F; de Bono DP; Lubsen J; Tijssen JG; Serruys PW; Verstraete M
    Circulation; 1992 Jul; 86(1):111-20. PubMed ID: 1617763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.